MOLYBDENUM TOXICITY



MOLYBDENUM TOXICITY (MOLYBDENOSIS)
            Molybdenum is an essential trace element, a component of several enzymes. Excessive dietary intake of molybdenum induces a secondary hypocuprosis. The syndrome, predominately reported in ruminants. Cattle and sheep are ~10-fold more susceptible than other species. Acute toxicity associated with massive doses is rarely encountered.
Etiology
            Ingestion of hay contaminated by Mo from industrial sources (iron foundaries, steel works). Industrial contamination associated with mining or metal production or areas using molybdenum-contaminated fertilizers result in enhanced uptake of molybdenum by plants used as a feed source. Deficiency of copper in soils and in vegetation increases the toxicity of Mo which can then prove toxic at levels which are normally considered to be safe.
Toxicodynamics
            The interactions associated with copper, molybdenum, and sulfate metabolism related to the utilization, bioavailability, and kinetics of copper are among the most biologically significant interrelationships in veterinary medicine. In ruminants, various molybdates react with sulfides to produce thiomolybdate compounds, which react with copper to form an insoluble complex that is poorly absorbed. The reduced copper absorption impairs copper utilization and the synthesis of a variety of copper-dependent proteins. The reduced bioavailability of copper ultimately induces secondary copper deficiency. Excessive molybdenum intake also enhances the excretion of copper. Based on this observation, the administration of tetrathiomolybdates may be a useful treatment for chronic copper poisoning. The limited bacterial formation of thiomolybdates in monogastric animals is primarily responsible for the tolerance to molybdenum encountered in these species. Excessive molybdenum exposure may also impair a variety of enzymes involved in collagen and elastin maintenance and stability, which has been associated with cardiovascular disorders. Molybdenum exposure may reduce phospholipid synthesis in nervous tissue, resulting in demyelination and neurologic disorders clinically.
Factors modifying toxicity
            The susceptibility to molybdenum toxicity in ruminants depends on a number of factors, including
1) dietary copper content - susceptibility increases as the copper content decreases;
2) dietary sulfate content - susceptibility increases with high sulfate levels by impairing copper utilization, whereas low sulfate content enhances susceptibility by reducing molybdenum excretion;
3) the chemical form of molybdenum - water-soluble forms found in fresh feed are more toxic;
4) sulfur-containing amino acids may alter copper utilization or molybdenum excretion;
5) animal species - cattle are more susceptible;
6) age - young animals are more susceptible, and excretion of molybdenum into milk may produce toxicoses in nursing calves;
7) season of year - molybdenum concentrations in plants increase in the fall;
8) plant species - legumes bioaccumulate more molybdenum; and
9) breed differences - seen in sheep and goats.
Clinical Findings
            The manifestations of molybdenum toxicity are related primarily to impaired copper metabolism and utilization, resulting in secondary copper deficiency. Typically, the syndrome is a herd problem, with morbidity as high as 80%.
Gastrointestinal
            Watery, foetid diarrhoea refractory to all treatment (severe, persistent diarrhea with the presence of green, liquid feces containing gas bubbles, often referred to as peat or teart scours).
Skeletal
            Molybdenum competes with phosphorus utilization, resulting in reduced mineralization of bone.
            Deformation of the long bones of the body (exostoses).
            Limping (due to skeletal pain).
            Presence or absence of osteophytes.
            Spontaneous fractures of the long bones.
            Joint pain characterized by lameness, and osteoporosis often manifested by bone fractures.
            In sheep, particularly in lambs <30 days old, the animals exhibit stiffness of the back and legs and have difficulty rising. The syndrome in sheep is known as enzootic ataxia, or sway back.
            Abnormal development of connective tissue and growth plates are apparent in affected animals.
Cutaneous
            Fragile hair, easily pulled out.
            Disturbance of hair pigmentation (yellow discolouration in white-coated species).    Depigmentation, resulting in fading achromotrichia of the hair coat is evident in black animals associated with impaired tyrosinase activity and reduced melanin synthesis.

General
            Anaemia (microcytic hypochromic anemia).
            Pica, unthriftiness, loss of weight, cachexia.
            Death occurs within a few days to several weeks.
Reproductive
            In heifers, fertility is reduced. Delayed puberty, poor conception rates, decreased weight at puberty, and decreased milk production are common. Reduced libido has been reported in bulls.
            Manifestations appear within 1–2 wk if molybdenum levels are excessive.
            Occasionally, acute toxicity may be encountered in cattle or sheep. Anorexia and lethargy may be evident within 3 days. Deaths begin within 1 wk and may continue for many months. Neonates frequently exhibit hindlimb ataxia that often progresses to the forelimbs. Salivation and scant mucoid feces are common.
Lesions
            Emaciation (reduced body fat), cachexia, osteoporosis, deformation of the long bones, greenstick fractures, haemorrhages and breakdown of the periosteum, hypochromic anaemia, loss of hair pigmentation. At necropsy, hemosiderosis, periacinar to severe hepatic necrosis, and nephrosis are evident. In affected sheep, neuronal degeneration, demyelination, and lysis of white matter are seen in nervous tissue.
Diagnosis
            Distinguishing between primary copper deficiency and secondary copper deficiency related to excessive molybdenum exposure is important. Often with molybdenum toxicity, there is a poor correlation between tissue concentrations of copper and clinical disease. Clinical improvement after copper sulfate administration provides valuable support for the diagnosis. Analysis of the ration for copper and molybdenum concentrations is recommended. In cattle rations, a copper:molybdenum ratio of 6:1 is optimal. If the ratio is less than 2:1, molybdenum toxicity will occur. Ratios exceeding 15:1 may cause chronic copper poisoning. Absolute molybdenum concentrations in the diet >10 mg/kg will cause poisoning independent of copper consumption. Massive molybdenum exposure in the ration >2,000 mg/kg will result in death. Analysis of the liver and plasma for molybdenum provides useful insight to confirm the diagnosis, but the concentrations must be interpreted in association with the comparable tissue concentrations of copper. In cattle, liver concentrations >2 ppm (wet weight) and plasma concentrations >0.1 ppm are consistent with a diagnosis of molybdenum poisoning in the presence of a low copper status.
            Other disease syndromes characterized by emaciation or unthriftiness (parasite infections, selenosis, fluorosis, ergotism), diarrhea (metal poisonings, GI infections), and lameness or bone abnormalities (fluorosis, selenosis, ergotism, lead poisoning) may resemble molybdenum poisoning and should be investigated as possible etiologies.
Treatment and Prevention
            If the source of molybdenum can be removed, excess molybdenum is rapidly eliminated and food products are safe for consumption within a relatively short time.
            If the dietary exposure cannot be reduced, elimination of molybdenum in the milk may produce toxicosis in nursing calves. Dietary supplementation with copper sulfate will reduce the bioavailability of molybdenum in the GI tract, ultimately reducing absorption and enhancing excretion.
            In feed containing molybdenum at >5 mg/kg, supplementation with 1% copper sulfate in salt will control development of the syndrome.
            In recovered mining areas, the supplementation may need to be increased to as much as 5% copper sulfate in the salt.
            When the consumption of mineral supplements is impractical, the treatment may be administered as a weekly drench. Injectable products such as copper glycinate or copper edetate (Cu-EDTA) may be given at a dose of 120 mg/cow.
            Oral copper sulphate (solution), 1g/50kg body weight.
            Copper sulphate, 1-5%, in mineral salt licks.
            I.M. copper glycinate, 60 mg for calves, 120 mg for adult cattle, repeated every 6 months.

            Most treatment options are associated with the biological interactions associated with copper, molybdenum, and sulfate. Under circumstances in which dietary exposure is difficult to eliminate, simple treatment with copper products may be futile.
Laboratory investigations
            Liver, blood;
            Sample of contaminated feed.

Comments

Popular posts from this blog

Pharmacokinetics - Drug absorption and Transport of drugs across biological membranes

Skeletal muscle relaxants

PHARMACOGNOSY - SOURCES AND COMPOSITION OF DRUGS